Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  DexCom, Inc.    DXCM

DEXCOM, INC. (DXCM)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/18/2018 06/19/2018 06/20/2018 06/21/2018 06/22/2018 Date
100.89(c) 100.81(c) 100.65(c) 99.74(c) 99.56(c) Last
742 664 623 978 761 732 1 044 187 1 102 955 Volume
+1.17% -0.08% -0.16% -0.90% -0.18% Change
More quotes
Financials (USD)
Sales 2018 861 M
EBIT 2018 -40,7 M
Net income 2018 -42,6 M
Finance 2018 185 M
Yield 2018 -
Sales 2019 999 M
EBIT 2019 -4,21 M
Net income 2019 -16,9 M
Finance 2019 272 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 9,96x
EV / Sales2019 8,50x
Capitalization 8 769 M
More Financials
Company
DexCom, Inc. is a medical device manufacturing company, which engages in the design, development, and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes.Its products include Dexcom G4 PLATINUM System, Dexcom studio and Mobile apps.The company was... 
More about the company
Surperformance© ratings of DexCom, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on DEXCOM, INC.
06/20DEXCOM : Team Novo Nordisk Announces Partnership with Dexcom - the Global Leader..
AQ
06/19NOVO NORDISK A/S : Team Novo Nordisk Announces Partnership with Dexcom - the Glo..
AQ
06/12DEXCOM : G6® CGM System Receives CE Mark
BU
06/12DEXCOM : G5 CGMSystem Now Available on Mobile, Smart Devices for Medicare Patien..
AQ
06/12DEXCOM : G5 Continuous Glucose Monitoring System Now Available on Mobile, Smart ..
BU
06/05DEXCOM : Federal Court Judge Awards AgaMatrix Attorneys' Fees While Admonishing ..
PR
06/04DEXCOM INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/04DEXCOM, INC. : Stock Performance Review on Exact Sciences and Three Other Medica..
AC
05/17DEXCOM : Announces Upcoming Conference Presentation
BU
05/03DEXCOM : revenue jumps ahead of launch of latest wearable glucose monitor for di..
AQ
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
06/22LUXOTTICA : Italy's Luxottica buys sun lens maker Barberini for 140 million euro..
RE
06/15Essilor Calls General Meeting for EssilorLuxottica
DJ
06/14STRYKER : Says It Isn't in Deal Talks -- WSJ
DJ
06/13STRYKER : Says It Isn't in Deal Talks With Boston Scientific -- Update
DJ
06/13STRYKER : Says It's Not in Deal Talks with Boston Scientific
DJ
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
06/21FDA OKs Tandem's t:slim X2 insulin pump with hypoglycemia management feature;..
2
06/21FDA OKs Senseonics' Eversense CGM device; shares up 1%
1
06/21Dexcom $DXCM Expected to Announce Earnings of -$0.20 Per Share  
06/21Terrance H. Gregg Sells 10,000 Shares of Dexcom $DXCM Stock  
06/20Terrance H. Gregg Sells 10,000 Shares of Dexcom $DXCM Stock  
More tweets
Qtime:103
News from SeekingAlpha
06/21FDA OKS TANDEM'S T : slim X2 insulin pump with hypoglycemia management feature; .. 
06/21FDA OKs Senseonics' Eversense CGM device; shares up 1% 
06/18Can Fitbit Be Worth $15 By The End Of The Year? 
06/15Buy Lockheed Martin On Weakness - Cramer's Lightning Round (6/14/18) 
06/12Dexcom G6 CGM System receives CE mark 
Chart DEXCOM, INC.
Duration : Period :
DexCom, Inc. Technical Analysis Chart | DXCM | US2521311074 | 4-Traders
Technical analysis trends DEXCOM, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 89,3 $
Spread / Average Target -10%
EPS Revisions
Managers
NameTitle
Kevin Ronald Sayer President, Chief Executive Officer & Director
Terrance H. Gregg Executive Chairman
Jeffrey C. Moy Senior Vice President-Operations
Quentin Blackford Chief Financial Officer
Jacob Leach Senior Vice President-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
DEXCOM, INC.73.48%8 769
MEDTRONIC PLC7.26%117 660
BAXTER INTERNATIONAL14.98%39 970
ALIGN TECHNOLOGY58.99%28 314
TERUMO CORP24.16%23 057
ZIMMER BIOMET HOLDINGS-7.59%22 718